Amro Mohamed Sedky El-Ghammaz

6PUBLICATIONS
2CO-AUTHORS
Predictive and prognostic markersHaematological tumoursEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 03, 2021
Impact of serum soluble CD155 level at diagnosis on interim response to CHOP with or without rituximab in diffuse large B cell lymphoma.

Mohamed Osman Azzazi, Hany Mohamed Hegab, Amro Mohamed Sedky El-Ghammaz

|Mar 12, 2021
Prognostic Impact of Serum Growth Differentiation Factor 15 Level in Acute Myeloid Leukemia Patients.

Hany Mohamed Hegab, Amro Mohamed Sedky El-Ghammaz, Mostafa Kamal El-Razzaz

|Oct 26, 2020
Effectiveness and Cost-Effectiveness of Prophylactic Voriconazole and Fluconazole Regarding Prevention of Post-hematopoietic Stem Cell Transplantation Invasive Fungal Infection and Its Related Death: A Single Center Experience.

Amro Mohamed Sedky El-Ghammaz, Maha El-Zimaity, Amal Mostafa Elafifi

|Feb 02, 2020
Prognostic significance of serum progranulin level in de novo adult acute lymphoblastic leukemia patients.

Amro M S El-Ghammaz, Mohamed O Azzazi, Nevine Mostafa

|Nov 20, 2019
Impact of Additional Chromosomal Aberrations Present at Diagnosis on Outcome of Adolescent and Young Adult Chronic Myeloid Leukemia Patients: A Single Center Experience.

Amro Mohamed Sedky El-Ghammaz, Mohamed Tarif Hamza, Rasha Magdy Said

|Jun 08, 2018
Impact of serum soluble programed death ligand 1 on end of treatment metabolic response of diffuse large B cell lymphoma patients.

Amro Mohamed Sedky El-Ghammaz, Hoda Ahmed Gadallah, Gihan Kamal

Pageof 1